Skip to main content
. 2021 Jan 4;24(4):216–220. doi: 10.5114/wo.2020.102818

Table 2.

Biochemical parameters of the three studied groups

Characteristics Control (n = 50) Patients with hepatitis C without HCC (n = 50) Patients with HCV-related HCC(n = 50) Test of sig. p-value
ALT (U/l), mean ±SD 20.70 ±4.94 46.0 ±17.87 69.54 ±21.75 F = 109.535* < 0.001*
AST (U/l), mean ±SD 24.32 ±7.74 51.83 ±22.47 83.04 ±22.56 H = 107.496* < 0.001*
Albumin (gm/dl), mean ±SD 4.74 ±0.41 3.88 ±0.85 2.20 ±0.58 F = 201.361* < 0.001*
D.Bil. (mg/dl), mean ±SD 0.31 ±0.15 0.45 ±0.18 2.50 ±1.18 H = 107.789* < 0.001*
Sig. bet. grps p1 < 0.05*, p2 < 0.001*, p3 < 0.001*

ALT – alanine aminotransferase, AST– aspartate aminotransferase, D.Bil – direct bilirubin, F – ANOVA test, H – Kruskal-Wallis test, pairwise comparison bet. each 2 groups was done using Post Hoc Test, p – p-value for comparing between the studied groups, p1 – p-value for comparing between control and HCV, p2 – p-value for comparing between the control and HCC, p3 – p-value for comparing between the HCV and HCC, *statistically significant at p ≤ 0.05